Bone morphogenetic protein use in anterior cervical spine surgery: A review of current Literature concerning indications, safety, and efficacy

Keyphrases

• Anterior Cervical Spine Surgery 100%
• Bone Morphogenetic Protein 100%
• Cervical Spine 50%
• Containment 50%
• Fibula Graft 50%
• Fusion Rate 50%
• Hematoma Formation 50%
• Iliac Crest Bone Graft 50%
• Life-threatening Complications 50%
• Midline Neck Swelling 50%
• Multi-level Fusion 50%
• Prolonged Hospitalization 50%
• Prolonged Treatment 50%
• Protein Use 100%
• Recombinant Human Bone Morphogenetic Protein 100%
• Repeat Surgery 50%
• Seroma Formation 50%
• Severe Dysphagia 50%
• Subaxial Cervical Spine 50%
• Surgeons 50%

Medicine and Dentistry

• Bone Morphogenetic Protein 100%
• Cervical Spine 50%
• Fibula Graft 25%
• Hematoma 25%
• Iliac Crest 25%
• Neck Swelling 25%
• Plummer-Vinson Syndrome 25%
• Seroma 25%
• Spine Surgery 100%
• Surgeon 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Bone Morphogenetic Protein 100%
• Dysphagia 25%
• Hematoma 25%
• Neck Swelling 25%
• Seroma 25%